The10th anniversary edition of the NovAliX Conference aims to address the major developments of the last thirty years that affected the discovery sector, not only at the scientific level, but also in terms of industrial organisation of the drug discovery part and its financing, of the academia-industry relationships, and more.
Session
Unmet Therapeutic Needs: Current Challenges
Date: Tuesday, 14 June 2024
Time: 9:00-10:25 CEST
Session chair: Sylwia Huber, Biophysics Team Head, F. Hoffmann-La Roche
| Drug discovery for neglected patients: Past experience, present strategy and future directions Charles Mowbray, Discovery Director, DNDi |
| Building a Pipeline of High-Impact Products to Prevent, Diagnose and Treat Bacterial Infections Erin Duffy, Chief of Research & Development, CARB-X |
